Cargando…
Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report
Regorafenib, an oral multikinase inhibitor, was approved in September 2012 by the US Food and Drug Administration for the treatment of patients with metastatic colorectal cancer. Since this time, however, few case reports outlining real-world usage have been published in the literature. Here, we det...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657800/ https://www.ncbi.nlm.nih.gov/pubmed/26640390 http://dx.doi.org/10.2147/CMAR.S91547 |